NuCana, announced the appointment of Martin J Birkhofer, M.D. as Chief Medical Officer. Dr. Birkhofer, an oncologist by training, joins the company from inVentiv Health Clinical, where he led its global medical and scientific affairs and held the title of Chief Medical Officer. He brings to NuCana a broad drug development experience, and the knowhow of the evolving access, reimbursement and commercialization environment for oncology products.

The company announced the opening of a U.S. office in Princeton, New Jersey, which will establish a U.S. presence for the company and support NuCana's international clinical study programmes and other activities.